Company: CHNR
Filing Date: 2025-05-15
Form Type: 424B5
Source: 0001079973-25-000830
Chunk: 27

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-05-15
Form: 424B5
Chunk 27
---
 the Warrants for cash and without adjustment; and 
 •	excludes all Common Shares issuable upon exercise of our outstanding                                                               
 options and Common Shares reserved for future issuances under our share incentive plan.                                              |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

| S-12 |

<div align='center'>RISK FACTORS</div>

Investing in our Common Shares involves significant risks. You should carefully consider the risks described below and under “Item 3. Key Information - D. Risk Factors” in our annual report on Form 20-F for the fiscal year ended December 31, 2024 and in the “Risk Factors” section in the accompanying prospectus. If any of these risks actually occurs, our business, financial condition and results of operations could suffer, and you may lose all or part of your investment.

Please see “Where You Can Find More Information” and “Incorporation of Certain Documents by Reference” for information on where you can find the documents we have filed with or furnished to the SEC and which are incorporated by reference into the accompanying prospectus.

The warrants in this offering may not have any value.

The warrants offered hereby do not confer any rights
of share ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to
acquire our common shares at a fixed price. Specifically, commencing on the date of issuance, holders of the warrants may acquire the
common shares issuable upon exercise of such warrants at an exercise price of US$3.00 or US$2.20 per share, as applicable. All of the
warrants expire on August 21, 2027. Upon expiry of the term, the warrants will expire and have no further value. Moreover, following this
offering, the market value of the warrants is uncertain and there can be no assurance that the market price of the common shares will
ever equal or exceed the exercise price of the warrants, and consequently, whether it will ever be profitable for the holders of the warrants
to exercise the warrants.

The warrants in this offering do not entitle the holder to any rights as shareholders until the holder exercises the warrants for our common shares.

Until holders acquire our common shares upon exercise
of the warrants offered, such warrants will not provide holders any rights as a shareholder, except as set forth in the warrants. Upon
exercise of the warrants, holders will be entitled to exercise the rights of a shareholder only as to matters for which the record date
occurs